Healthcare and austerity

Health 08-12-2017

Drug pricing debate to take place in heated atmosphere

Following a Greek government request, the Employment, Social Policy, Health and Consumer Affairs Council (EPSCO) will discuss on Friday (8 December) a recent dispute between Athens and ROCHE, a Swiss multinational company, over the latter’s decision to withdraw a cancer drug from the market.

Health 08-11-2017

Europe’s excluded are falling through the cracks of healthcare

Whether it is an elderly German man who lost his job or a young boy that reached Europe fleeing war at home, Europe’s excluded are falling through the cracks of healthcare systems, writes Médecins du Monde.

Health 02-11-2017

Pharmaceutical company gives free access to drug after clash with Greek government

Following a clash with the Greek government over its decision to withdraw a cancer drug from the market, ROCHE, a Swiss multinational company, ultimately decided to make the drug available to patients for free.

Health 25-10-2017

Greek government on collision course with pharmaceutical companies over innovative drugs

Several pharmaceutical companies in Greece have threatened to stop supplying the market with innovative drugs and said they could even withdraw existing drugs as a result of an obligatory “discount” imposed by the Greek government and applied retroactively.

OpinionPromoted content
Health 18-10-2017

Access to medicines: Let’s have better care, for more patients

Marc-Alexander Mahl is President of Medicines for Europe. Europe’s healthcare model is under pressure. Populations are ageing in Europe – with the number of Europeans aged 65 or over set to rise by 45 million between 2015 and 2050.(1) This brings with it greater healthcare costs: currently, around 50 million EU citizens are estimated to suffer …

Health 12-10-2017

Patients: ‘Think carefully’ before questioning orphan drugs’ incentives

Organisations of patients with rare diseases have warned EU policymakers to “think carefully” before reviewing the incentives in the orphan drugs regulation, claiming that the pharma industry should not be discouraged from investing in new therapies.

Health 10-10-2017

Pharma boss: Targeting drugs won’t make healthcare systems more sustainable

“Salami-slicing” the cost of medicines, which represent almost one-fifth of health system budgets and are subject to rigorous value assessments, won’t make healthcare systems more sustainable in the future, Nathalie Moll told EURACTIV.com in an interview.

EU agency OK’d 39 cancer drugs without evidence they work, study shows

The European Medicines Agency approved 39 new cancer drugs between 2009 and 2013 despite having no evidence that they worked, unnecessarily exposing patients to toxicity, researchers said Thursday (5 October).

Health 28-06-2017

Antibiotic resistance is the best case for ‘more Europe’

No country alone can tackle antimicrobial resistance and therefore an effective EU response is needed, backed up by policies and funds, writes Nina Renshaw.

Alcohol 21-06-2017

Alcohol makers brace for EU-wide mandatory labelling

Makers of spirits and beer are exploring self-regulatory solutions to show consumers the ingredients contained in the alcohol they drink. However, they find the Commission's timeline "too tight" and fear mandatory rules will eventually be imposed on them.

Active ageing 14-06-2017

Report finds human rights abuses in Europe’s nursing homes

Ahead of the World Elder Abuse Awareness Day tomorrow (15 June), a new report heats up the discussion about the conditions of the elderly in Europe’s nursing homes.

Health 16-05-2017

Commission opens first investigation into excessive drug pricing

The European Commission announced yesterday (15 May) that it opened a formal investigation into Aspen Pharma's pricing practices for cancer drugs.